학술논문
Vitreous Opacity Following Intravitreal Brolucizumab Injection: A Case Series Review
이용수 0
- 영문명
- Vitreous Opacity Following Intravitreal Brolucizumab Injection: A Case Series Review
- 발행기관
- 대한안과학회
- 저자명
- Kook Hyung Lee Sung Chul Lee Min Woo Lee
- 간행물 정보
- 『The Korean Journal of Ophthalmology』Vol.38 No.2, 113~121쪽, 전체 9쪽
- 주제분류
- 의약학 > 의학일반
- 파일형태
- 발행일자
- 2024.04.30
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

국문 초록
영문 초록
Purpose: To investigate cases of vitreous opacity (VO) similar to asteroid hyalosis (AH) after intravitreal brolucizumab injection.
Methods: A retrospective chart review was conducted to identify cases showing VO similar to AH among patients who received intravitreal brolucizumab injections at our retinal clinic from January 2022 to January 2023.
Results: A total of 220 brolucizumab injections were administered at our hospital. VO, showing yellow-white brilliant reflective particles, was found in six patients (2.7%). When VO occurred, all patients complained of floaters, although none of them complained of other symptoms including decreased visual acuity, pain, or conjunctival redness. The mean number of brolucizumab injections was 2.57 ± 2.38. No significant visual impairment was observed while VO was present. VO improved in all cases, and four cases improved without any treatment. The mean interval from onset to disappearance of VO was 8.0 ± 3.1 weeks.
Conclusions: VO, similar to AH, can occur with a relatively high probability after intravitreal brolucizumab injections. Patients complained of severe floaters, but VO was not accompanied by other symptoms including vision impairment, injection, and pain. The VO disappeared after approximately 4 to 14 weeks. In case that other inflammatory findings are not severe, close follow-up without treatment may be sufficient. If a patient complains of floaters after an intravitreal brolucizumab injection, close fundus observation is necessary to evaluate the VO.
목차
Materials and Methods
Results
Discussion
References
해당간행물 수록 논문
- Clinical Performance Comparison of Ultrahigh-speed Dual Pneumatic Vitrectomy Probes: Is Faster and Smaller Better?
- Successful Treatment of Orbital Lymphatic Malformation Using Foam Sclerotherapy with 3% Sodium Tetradecyl Sulfate: A Case Report
- Utilization of Cavitron Ultrasonic Surgical Aspirator in the Removal of Extensive Orbital Cavernous Venous Malformation: A Case Report
- One-year Outcomes of Ultrathin Descemet Stripping Automated Endothelial Keratoplasty Combined with Cataract Surgery in the Korean Population
- Efficacy and Rapidity of Potassium Hydroxide Mount and Modified Chicago Sky Blue 6B Stain with Potassium Hydroxide in Fungal Keratitis Detection
- Visual Recovery Time in Patients with Ethambutol-induced Toxic Optic Neuropathy
- Long-term Results after Bilateral Implantation of Extended Depth of Focus Intraocular Lenses with Mini-Monovision
- Severe Phenotypic Presentation of RPGR -associated X-linked Retinitis Pigmentosa in Female Carriers: Two Case Reports
- Vitreous Opacity Following Intravitreal Brolucizumab Injection: A Case Series Review
- Changes in Retinal Hemodynamics in the Optic Nerve Head of Healthy Participants Measured Using Laser Speckle Flowgraphy after a Cold Pressor Test
- The Relationship between Myopia and Obesity in Adults
- New Korean Guidelines for the Diagnosis and Management of Dry Eye Disease
- Pseudoexfoliation Syndrome Showing Different Deposition Patterns in Pseudophakic Eyes: Two Case Reports
- Uveitis with Hyphema Mimicking Infectious Endophthalmitis after Glaucoma Filtering Surgery: A Case Report
참고문헌
관련논문
의약학 > 의학일반분야 BEST
- 간호대학생의 인공지능 활용 간호수행 자신감에 영향을 미치는 요인
- 국내 의료기관의 환자안전사고 관련 요인 분석: 2019-2022년 환자안전보고 데이터 활용 이차분석 연구
- 지역사회 인지저하 전·후기 노인의 건강 및 돌봄 요구 실태
의약학 > 의학일반분야 NEW
- Management of Baras (Vitiligo) with Babchi (Psoralea corylifolia) and Micro-needling: A Case Report
- Analysis of modern and korean medicine treatments for chronic obstructive pulmonary disease
- Lorafocin, a mixture of Eunkyosan and alginate attenuate LPS-induced inflammation in RAW264.7 cells and inhibit growth of infectious bacteria
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
